- Home
- KALA vs GAME Comparison
KALA vs GAME Comparison
Compare KALA & GAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- GAME
- Stock Information
- Founded
- KALA 2009
- GAME 2011
- Country
- KALA United States
- GAME United States
- Employees
- KALA N/A
- GAME N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- GAME
- Sector
- KALA Health Care
- GAME
- Exchange
- KALA Nasdaq
- GAME Nasdaq
- Market Cap
- KALA 26.2M
- GAME 27.2M
- IPO Year
- KALA 2017
- GAME 2009
- Fundamental
- Price
- KALA $5.10
- GAME $0.89
- Analyst Decision
- KALA Strong Buy
- GAME Strong Buy
- Analyst Count
- KALA 3
- GAME 3
- Target Price
- KALA $14.00
- GAME $3.67
- AVG Volume (30 Days)
- KALA 71.3K
- GAME 484.0K
- Earning Date
- KALA 08-05-2025
- GAME 08-13-2025
- Dividend Yield
- KALA N/A
- GAME N/A
- EPS Growth
- KALA N/A
- GAME N/A
- EPS
- KALA N/A
- GAME N/A
- Revenue
- KALA N/A
- GAME $99,579,536.00
- Revenue This Year
- KALA N/A
- GAME $6.08
- Revenue Next Year
- KALA N/A
- GAME $21.94
- P/E Ratio
- KALA N/A
- GAME N/A
- Revenue Growth
- KALA N/A
- GAME 77.06
- 52 Week Low
- KALA $2.92
- GAME $0.50
- 52 Week High
- KALA $11.20
- GAME $1.37
- Technical
- Relative Strength Index (RSI)
- KALA 62.32
- GAME 59.56
- Support Level
- KALA $4.36
- GAME $0.73
- Resistance Level
- KALA $5.90
- GAME $0.97
- Average True Range (ATR)
- KALA 0.50
- GAME 0.07
- MACD
- KALA 0.07
- GAME 0.01
- Stochastic Oscillator
- KALA 61.50
- GAME 73.79
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is engaged to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Its next generation media, entertainment, and technology help creators and maximize its brand partners return on investment. Its purpose-built platform, provide marketing and creative services, offer data and analytics solutions, and amplify awareness through FaZe Clan.